Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0756
D

Failure to Document Gradual Dose Reduction or Justification for Psychotropic Medication Use

Grand Rapids, Minnesota Survey Completed on 05-21-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that the consulting pharmacist (CP) identified the need for a gradual dose reduction (GDR) or provided medical justification for the continued use of psychotropic medications for one resident reviewed. The resident in question had moderate cognitive impairment, exhibited verbal behaviors, and had diagnoses including bipolar disorder and anxiety. The resident was prescribed both an antipsychotic (haloperidol) and an antidepressant (Zoloft), with the last documented GDR attempt occurring over a year prior. There was no documentation in the medical record of a GDR attempt or a clinical justification for the ongoing use of these medications within the past year. Monthly pharmacy reviews conducted from June 2024 to May 2025 did not identify any irregularities with the resident's psychotropic medications. Interviews with facility staff, including a registered nurse and the CP, confirmed that the resident's record lacked evidence of a recent GDR or a documented contraindication. The facility's policy required monthly reviews and recommendations for dosage reductions or modifications as appropriate, but this process was not followed for the resident in question.

An unhandled error has occurred. Reload 🗙